A Look Ahead: Arrowhead Pharma's Earnings Forecast
A Look Ahead: Arrowhead Pharma's Earnings Forecast
It's important for new investors to understand that guidance can be a significant driver of stock prices.Arrowhead Pharma (NASDAQ:ARWR) is set to give its latest quarterly earnings report on Tuesday, 2024-11-26. Here's what investors need to know before the announcement.
Arrowhead Pharma（納斯達克股票代碼：ARWR）定於2024-11-26星期二發佈其最新的季度收益報告。以下是投資者在宣佈之前需要了解的內容。
Analysts estimate that Arrowhead Pharma will report an earnings per share (EPS) of $-1.05.
分析師估計，Arrowhead Pharma將公佈的每股收益（EPS）爲-1.05美元。
The market awaits Arrowhead Pharma's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
市場正在等待Arrowhead Pharma的宣佈，對超出預期併爲下一季度提供樂觀指導的消息寄予厚望。
It's important for new investors to understand that guidance can be a significant driver of stock prices.
對於新投資者來說，重要的是要明白，指引可以成爲股價的重要驅動力。
Performance in Previous Earnings
先前收益的表現
The company's EPS missed by $0.83 in the last quarter, leading to a 9.44% drop in the share price on the following day.
該公司上個季度的每股收益下降了0.83美元，導致第二天股價下跌9.44％。
Here's a look at Arrowhead Pharma's past performance and the resulting price change:
以下是Arrowhead Pharma過去的表現以及由此產生的價格變化：
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.55 | -0.16 | -0.82 | -0.60 |
| EPS Actual | -1.38 | -1.02 | -1.24 | -1.02 |
| Price Change % | -9.0% | -11.0% | -5.0% | -27.0% |
| 季度 | 2024 年第三季度 | 2024 年第二季度 | 2024 年第一季度 | 2023 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.55 | -0.16 | -0.82 | -0.60 |
| 實際每股收益 | -1.38 | -1.02 | -1.24 | -1.02 |
| 價格變動% | -9.0% | -11.0% | -5.0% | -27.0% |
Arrowhead Pharma Share Price Analysis
Arrowhead Pharma 股價分析
Shares of Arrowhead Pharma were trading at $18.54 as of November 22. Over the last 52-week period, shares are down 35.89%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
截至11月22日，Arrowhead Pharma的股票交易價格爲18.54美元。在過去的52週中，股價下跌了35.89％。鑑於這些回報率通常爲負數，長期股東在發佈本業績時可能會感到沮喪。
To track all earnings releases for Arrowhead Pharma visit their earnings calendar on our site.
要追蹤Arrowhead Pharma發佈的所有業績，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動化內容引擎生成，並由編輯審閱。
